510(k) K183176
K183176 is an FDA 510(k) premarket notification submitted by Spectral Medical, Inc. for the device "Endotoxin Activity Assay (EAA)". The FDA issued a decision of Substantially Equivalent on Mar 12, 2019. The device falls under product code NGS (Assay, Endotoxin Activity, Chemiluminescent), a Class II device regulated under 21 CFR 866.3210. Spectral Medical, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 12, 2019
- Date Received
- Nov 16, 2018
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Assay, Endotoxin Activity, Chemiluminescent
- Device Class
- Class II
- Regulation Number
- 866.3210
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Spectral Medical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.